242 related articles for article (PubMed ID: 32418175)
1. Realgar (α-As
Zhang M; Zhang JY; Sun MQ; Lu P; Liu JX
Chin J Integr Med; 2022 Mar; 28(3):281-288. PubMed ID: 32418175
[TBL] [Abstract][Full Text] [Related]
2. Arsenic Disulfide Promoted Hypomethylation by Increasing DNA Methyltransferases Expression in Myelodysplastic Syndrome.
Zhou QB; Liu ZT; Wang HZ; Guo XQ; Xu YG; Hu XM
Drug Des Devel Ther; 2020; 14():1641-1650. PubMed ID: 32431489
[TBL] [Abstract][Full Text] [Related]
3. Arsenic concentration in peripheral blood is correlated with efficacy of a Traditional Chinese Medicine regimen containing realgar for the treatment of myelodysplastic syndrome.
Wang DX; Xu YG; Du Y; Wang HZ; Li L; Hu XM; Yang XP; Ma R; Zhou QB
J Tradit Chin Med; 2021 Aug; 41(4):630-635. PubMed ID: 34392657
[TBL] [Abstract][Full Text] [Related]
4. Realgar (As
Li Z; Zhang R; Yin X; Li N; Cui S; Wang T; Tan X; Shen M; Guo Y; Wang J; Guo D; Xu R
Aging (Albany NY); 2022 Sep; 14(17):7109-7125. PubMed ID: 36098742
[TBL] [Abstract][Full Text] [Related]
5. Arsenic sulfide, the main component of realgar, a traditional Chinese medicine, induces apoptosis of gastric cancer cells in vitro and in vivo.
Zhang L; Tian W; Kim S; Ding W; Tong Y; Chen S
Drug Des Devel Ther; 2015; 9():79-92. PubMed ID: 25565771
[TBL] [Abstract][Full Text] [Related]
6. Effects of arsenic disulfide on apoptosis, histone acetylation, toll like receptor 2 activation, and erythropoiesis in bone marrow mononuclear cells of myelodysplastic syndromes patients in vitro.
Xu M; Ren JY; Guo YC; Xu BX; Zeng Q; Hu Q; Zhou YM; Lu JH
Leuk Res; 2017 Nov; 62():4-11. PubMed ID: 28963909
[TBL] [Abstract][Full Text] [Related]
7. [Establishment of two-dimensional electrophoresis proteomic profiles of retinoid acid resistant human acute promyelocytic leukemia NB4-R1 cells with apoptosis induced by realgar].
Qi J; Zhang M; He PC
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Mar; 31(3):391-6. PubMed ID: 21485086
[TBL] [Abstract][Full Text] [Related]
8. [Methylation of P15INK4B gene in patients with myelodysplastic syndromes and demethylating effects of drugs].
Ye XS; Liu T; Cui X; Meng WT; Xi YM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):57-9. PubMed ID: 17294728
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of immunological changes following realgar and arsenic trioxide treatments in a murine model of myelodysplastic syndrome.
Tao Y; Xue T; Li X; Guo R; Wang Y; Xu H; Hu K; Dong X; Wang D; Ren J; Guan Y; Lu J
Immunopharmacol Immunotoxicol; 2024 Jun; 46(3):408-416. PubMed ID: 38816179
[TBL] [Abstract][Full Text] [Related]
10. The medicinal use of realgar (As₄S₄) and its recent development as an anticancer agent.
Wu J; Shao Y; Liu J; Chen G; Ho PC
J Ethnopharmacol; 2011 Jun; 135(3):595-602. PubMed ID: 21497649
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic modifications of splicing factor genes in myelodysplastic syndromes and acute myeloid leukemia.
Wong JJ; Lau KA; Pinello N; Rasko JE
Cancer Sci; 2014 Nov; 105(11):1457-63. PubMed ID: 25220401
[TBL] [Abstract][Full Text] [Related]
12. A review of cinnabar (HgS) and/or realgar (As
Liu J; Wei LX; Wang Q; Lu YF; Zhang F; Shi JZ; Li C; Cherian MG
J Ethnopharmacol; 2018 Jan; 210():340-350. PubMed ID: 28864167
[TBL] [Abstract][Full Text] [Related]
13. Mineral arsenicals in traditional medicines: orpiment, realgar, and arsenolite.
Liu J; Lu Y; Wu Q; Goyer RA; Waalkes MP
J Pharmacol Exp Ther; 2008 Aug; 326(2):363-8. PubMed ID: 18463319
[TBL] [Abstract][Full Text] [Related]
14. Effects of realgar (As
Niu M; Shen Y; Qi J; Liu X; Sang W; Wu Q; Cao J; Chen W; Yao Y; Xu K
Ann Hematol; 2017 Nov; 96(11):1945-1948. PubMed ID: 28821933
[No Abstract] [Full Text] [Related]
15. Negative effect of DNA hypermethylation on the outcome of intensive chemotherapy in older patients with high-risk myelodysplastic syndromes and acute myeloid leukemia following myelodysplastic syndrome.
Grövdal M; Khan R; Aggerholm A; Antunovic P; Astermark J; Bernell P; Engström LM; Kjeldsen L; Linder O; Nilsson L; Olsson A; Wallvik J; Tangen JM; Oberg G; Jacobsen SE; Hokland P; Porwit A; Hellström-Lindberg E
Clin Cancer Res; 2007 Dec; 13(23):7107-12. PubMed ID: 18056190
[TBL] [Abstract][Full Text] [Related]
16. Association of Gene Mutations with Response to Arsenic-Containing Compound Qinghuang Powder () in Patients with Myelodysplastic Syndromes.
Zhao P; Liang JB; Deng ZY; Wang MJ; Qin JY; Chen CJ; Hu XM
Chin J Integr Med; 2019 Jun; 25(6):409-415. PubMed ID: 29619748
[TBL] [Abstract][Full Text] [Related]
17. Arsenic sulfide promotes apoptosis in retinoid acid resistant human acute promyelocytic leukemic NB4-R1 cells through downregulation of SET protein.
Tian Y; Liu Y; He P; Liu F; Zhou N; Cheng X; Shi L; Zhu H; Zhao J; Wang Y; Zhang M
PLoS One; 2014; 9(1):e83184. PubMed ID: 24454695
[TBL] [Abstract][Full Text] [Related]
18. Reversal effect of arsenic sensitivity in human leukemia cell line K562 and K562/ADM using realgar transforming solution.
Wang X; Zhang X; Xu Z; Wang Z; Yue X; Li H
Biol Pharm Bull; 2013; 36(4):641-8. PubMed ID: 23358330
[TBL] [Abstract][Full Text] [Related]
19. Realgar-induced apoptosis and differentiation in all-trans retinoic acid (ATRA)-sensitive NB4 and ATRA-resistant MR2 cells.
Chen S; Fang Y; Ma L; Liu S; Li X
Int J Oncol; 2012 Apr; 40(4):1089-96. PubMed ID: 22134377
[TBL] [Abstract][Full Text] [Related]
20. Dissection of scientific compatibility of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia from the perspective of toxicology.
Jiang Z; Sun Y; Wu Z; Tang M; Ye A; Tu B; Yi J; Xu H; Gao Y
J Ethnopharmacol; 2023 Dec; 317():116895. PubMed ID: 37467822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
